Innocan Pharma Corporation (INNO:CSE) (IP4:FSE) has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
Visited 1 times, 1 visit(s) today
Last modified: July 13, 2026
